Petros Pharmaceuticals, Inc. Research And Development Expense

Quick Answer

Petros Pharmaceuticals, Inc. reported Research And Development Expense of $2.62 million for the year ending 2024.

  • Petros Pharmaceuticals, Inc. showed an increase of +8.5% in Research And Development Expense from 2023 to 2024.
  • This data is from Petros Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
  • XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2020 to 2024), Petros Pharmaceuticals, Inc.'s Research And Development Expense has grown by 468.9%.
  • Historical annual values: Fiscal year 2024: $2.62 million | Fiscal year 2023: $2.41 million | Fiscal year 2022: $1.74 million | Fiscal year 2021: $1.79 million | Fiscal year 2020: $459.6 thousand.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: